Rapid Line INC 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

OTC.Pink
Rapid Line Inc.'s Q2 2026 10-Q filing reveals persistent operational challenges, a substantial accumulated deficit, and significant doubts about its ability to continue as a going concern, despite a recent, unexplained surge in its stock price.
OTC.Pink
Rapid Line Inc. reports no revenue for Q1 2026, significant liabilities, and ongoing concerns about its ability to continue as a going concern, while management seeks additional funding.
OTC.Pink
Rapid Line Inc., a development stage company, reported a net loss of $30,305 for the third quarter ended October 31, 2025, while debt forgiveness led to a year-to-date net income of $39,781.
OTC.Pink
Rapid Line Inc. reported a net loss for the quarter ended July 31, 2025, with no revenue generated, while undergoing significant changes in control and management.
OTC.Pink
Rapid Line Inc. reported a net income of $98,283 for the first quarter ended April 30, 2025, primarily due to the forgiveness of $114,731 in debt by its former officer, despite generating no revenues and facing substantial doubt about its ability to continue as a going concern.
OTC.Pink
Rapid Line Inc.'s third quarter filing reveals continued losses and a reliance on debt financing, raising concerns about the company's ability to operate as a going concern.
OTC.Pink
Rapid Line Inc. reports no revenue and a net loss of $2,254 for the three months ended July 31, 2024, raising concerns about its ability to continue as a going concern.
OTC.Pink
Rapid Line Inc. reports a net loss of $19,622 for the three months ended April 30, 2024, raising concerns about its ability to continue as a going concern.